Paper22247604
Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model.
Xu RY and 4 others. J Clin Biochem Nutr, 2012. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. Papers, record 22247604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22247604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18186553 | Non-alcoholic fatty liver disease and the metabolic syndrome: an update. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18186553 | PubMed |
| 2 | 17690317 | Fatty liver: a novel component of the metabolic syndrome. | Arterioscler Thromb Vasc Biol | 2008 | https://conductscience.org/library/papers/17690317 | PubMed |
| 3 | 20209477 | Effect of vitamin E supplementation on oxidative stress in a rat model of diet-induced obesity. | Int J Vitam Nutr Res | 2009 | https://conductscience.org/library/papers/20209477 | PubMed |
| 4 | 18976829 | Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice. | Int J Food Microbiol | 2008 | https://conductscience.org/library/papers/18976829 | PubMed |
| 5 | 17995961 | Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria. | FEMS Immunol Med Microbiol | 2008 | https://conductscience.org/library/papers/17995961 | PubMed |
| 6 | 2516007 | Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. | Hepatogastroenterology | 1989 | https://conductscience.org/library/papers/2516007 | PubMed |
| 7 | 15942443 | Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. | J Clin Gastroenterol | 2005 | https://conductscience.org/library/papers/15942443 | PubMed |
| 8 | 19115316 | VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. | Hepatology | 2009 | https://conductscience.org/library/papers/19115316 | PubMed |
| 9 | 19337630 | Assessment of small intestinal permeability using 1H-NMR spectroscopy. | J Gastrointestin Liver Dis | 2009 | https://conductscience.org/library/papers/19337630 | PubMed |
| 10 | 3971127 | A 13-year review of jejunoileal bypass. | Br J Surg | 1985 | https://conductscience.org/library/papers/3971127 | PubMed |
| 11 | 17652039 | Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. | Dig Liver Dis | 2007 | https://conductscience.org/library/papers/17652039 | PubMed |
| 12 | 12713883 | Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. | J Hepatol | 2003 | https://conductscience.org/library/papers/12713883 | PubMed |
| 13 | 9547102 | Steatohepatitis: a tale of two "hits"? | Gastroenterology | 1998 | https://conductscience.org/library/papers/9547102 | PubMed |
| 14 | 10355850 | Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on delta6-desaturase activity in the livers of rats fed a fat- and cholesterol-enriched diet. | Nutrition | 1999 | https://conductscience.org/library/papers/10355850 | PubMed |
| 16 | 18286348 | High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. | Obes Surg | 2008 | https://conductscience.org/library/papers/18286348 | PubMed |
| 17 | 7806045 | Antibiotics prevent liver injury in rats following long-term exposure to ethanol. | Gastroenterology | 1995 | https://conductscience.org/library/papers/7806045 | PubMed |
| 18 | 6424583 | Intestinal permeability in the newborn. | Arch Dis Child | 1984 | https://conductscience.org/library/papers/6424583 | PubMed |
| 19 | 19164560 | Human gut microbiota in obesity and after gastric bypass. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19164560 | PubMed |
| 20 | 11156641 | The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. | Gut | 2001 | https://conductscience.org/library/papers/11156641 | PubMed |
| 21 | 12576600 | Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. | Microbiology (Reading) | 2003 | https://conductscience.org/library/papers/12576600 | PubMed |
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42243653 | Role of the gut microbiota-bile acid axis in liver fibrosis based on microbiomics and targeted metabolomics. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42243653 | PubMed |
| 41031109 | Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspective. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41031109 | PubMed |
| 40606926 | Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics. | World J Hepatol | 2025 | https://conductscience.org/library/papers/40606926 | PubMed |
| 39825360 | The association between the dietary index for gut microbiota and metabolic dysfunction-associated fatty liver disease: a cross-sectional study. | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/39825360 | PubMed |
| 39459500 | Saccharomyces boulardii Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39459500 | PubMed |
| 39444759 | The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies. | Int J Hepatol | 2024 | https://conductscience.org/library/papers/39444759 | PubMed |
| 39335920 | Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity. | Foods | 2024 | https://conductscience.org/library/papers/39335920 | PubMed |
| 39182075 | Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/39182075 | PubMed |
| 38770031 | Effects of sex on fat deposition through gut microbiota and short-chain fatty acids in weaned pigs. | Anim Nutr | 2024 | https://conductscience.org/library/papers/38770031 | PubMed |
| 38191502 | Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends. | Sci Rep | 2024 | https://conductscience.org/library/papers/38191502 | PubMed |
| 37845315 | Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. | Nat Microbiol | 2023 | https://conductscience.org/library/papers/37845315 | PubMed |
| 37291355 | Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota. | AMB Express | 2023 | https://conductscience.org/library/papers/37291355 | PubMed |
| 37237476 | Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37237476 | PubMed |
| 37129252 | Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease. | Am J Physiol Gastrointest Liver Physiol | 2023 | https://conductscience.org/library/papers/37129252 | PubMed |
| 37077519 | Microbiome-liver crosstalk: A multihit therapeutic target for liver disease. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37077519 | PubMed |
| 37038205 | State of the art in research on the gut-liver and gut-brain axis in poultry. | J Anim Sci Biotechnol | 2023 | https://conductscience.org/library/papers/37038205 | PubMed |
| 37007480 | Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37007480 | PubMed |
| 37005411 | Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice. | Nat Commun | 2023 | https://conductscience.org/library/papers/37005411 | PubMed |
| 36139402 | Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention. | Cells | 2022 | https://conductscience.org/library/papers/36139402 | PubMed |
| 35693397 | Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients. | Hepatobiliary Surg Nutr | 2022 | https://conductscience.org/library/papers/35693397 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AOC1 | 26 | PubTator's text mining | https://conductscience.org/library/genes/26 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22247604
GET https://conductscience.org/api/papers/v1/22247604/references?page=2